Abstracts - faqs.org

Abstracts

Personal finance

Search abstracts:
Abstracts » Personal finance

What's in store for 2004

Article Abstract:

A team of technical experts provides guidelines to investors related to economic predictions, legislative changes and market trends. It is advisable to review previous portfolio before strategizing for the coming year.

Author: Hely, Susan
Publisher: Fairfax Business Publication
Publication Name: Personal Investor (Melbourne, Vic.)
Subject: Personal finance
ISSN: 0813-2992
Year: 2004
Management dynamics, Methods, Practice, Investors, Investment management

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Tapping high yields in shares

Article Abstract:

The excellent performance of ING OneAnswer Investment Portfolio Tax-Effective Income Fund is discussed. The fund reaped the benefits from the good performance of the listed property trusts and bank shares it held.

Author: Hely, Susan
Publisher: Fairfax Business Publication
Publication Name: Personal Investor (Melbourne, Vic.)
Subject: Personal finance
ISSN: 0813-2992
Year: 2005
Australia, Trusts, Funds, Trusts, and Other Financial Vehicles, Analysis, Economic aspects, Trusts and trustees, Trusts (Law)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Portfolio management
Similar abstracts:
  • Abstracts: Taking stock for a new era. Taking stock offshore. Big growth promised by top drops
  • Abstracts: BT: back in the ring. Give yourself a brake
  • Abstracts: Growth stocks set for re-rating. Reporting season adds to jitters. Forget what was hot in 2002
  • Abstracts: Fast tracking financial success. Reaping ethical rewards. Put the heat on cold-callers
  • Abstracts: A balancing act. Taxing the house. Bubble, bubble tax and trouble
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.